2023
Rao SS, Lunde HS, Dolan DWP, Fond AK, Petersen K, Haugland GT. Front Immunol. 2023 14:1198211. 10.3389/fimmu.2023.1198211
2020
Nido GS, Dick F, Toker L, Petersen K, Alves G, Tysnes OB, Jonassen I, Haugarvoll K, Tzoulis C. Acta Neuropathol Commun. 2020 8(1):55. 10.1186/s40478-020-00932-7
2019
Sundstrøm T, Prestegarden L, Azuaje F, Aasen SN, Røsland GV, Varughese JK, Bahador M, Bernatz S, Braun Y, Harter PN, Skaftnesmo KO, Ingham ES, Mahakian LM, Tam S, Tepper CG, Petersen K, Ferrara KW, Tronstad KJ, Lund-Johansen M, Beschorner R, Bjerkvig R, Thorsen F. Acta Neuropathol Commun. 2019 7(1):55. 10.1186/s40478-019-0712-8
2018
49. Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer.
Kusonmano K, Halle MK, Wik E, Hoivik EA, Krakstad C, Mauland KK, Tangen IL, Berg A, Werner HMJ, Trovik J, Øyan AM, Kalland KH, Jonassen I, Salvesen HB, Petersen K. PLoS One. 2018 13(11):e0206665. 10.1371/journal.pone.0206665
48. A novel approach to identify highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer.
Kusonmano K, Halle MK, Wik E, Hoivik EA, Krakstad C, Mauland KK, Tangen IL, Berg A, Werner HMJ, Trovik J, Øyan AM, Kalland K-H, Jonassen I, Salvesen HB, Petersen K. BGRSSB-2018. 2018. 10.18699/BGRSSB-2018-034
Tekle KM, Gundersen S, Klepper K, Bongo LA, Raknes IA, Li X, Zhang W, Andreetta C, Mulugeta TD, Kalaš M, Rye MB, Hjerde E, Antony Samy JK, Fornous G, Azab A, Våge DI, Hovig E, Willassen NP, Drabløs F, Nygård S, Petersen K, Jonassen I. F1000Res. 2018 7:ELIXIR-968. 10.12688/f1000research.15119.1
Eggestøl HØ, Lunde HS, Rønneseth A, Fredman D, Petersen K, Mishra CK, Furmanek T, Colquhoun DJ, Wergeland HI, Haugland GT. Sci Rep. 2018 8(1):5261. 10.1038/s41598-018-23667-x
2017
Leiss L, Mutlu E, Øyan A, Yan T, Tsinkalovsky O, Sleire L, Petersen K, Rahman MA, Johannessen M, Mitra SS, Jacobsen HK, Talasila KM, Miletic H, Jonassen I, Li X, Brons NH, Kalland KH, Wang J, Enger PØ. BMC Cancer. 2017 17(1):108. 10.1186/s12885-017-3109-8
2016
44. RareVariantVis: new tool for visualization of causative variants in rare monogenic disorders using whole genome sequencing data.
Stokowy T, Garbulowski M, Fiskerstrand T, Holdhus R, Labun K, Sztromwasser P, Gilissen C, Hoischen A, Houge G, Petersen K, Jonassen I, Steen VM. Bioinformatics. 2016 32(19):3018-20. 10.1093/bioinformatics/btw359
43. EPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis.
Martin-Almedina S, Martinez-Corral I, Holdhus R, Vicente A, Fotiou E, Lin S, Petersen K, Simpson MA, Hoischen A, Gilissen C, Jeffery H, Atton G, Karapouliou C, Brice G, Gordon K, Wiseman JW, Wedin M, Rockson SG, Jeffery S, Mortimer PS, Snyder MP, Berland S, Mansour S, Makinen T, Ostergaard P. J Clin Invest. 2016 126(8):3080-8. 10.1172/JCI85794
2015
42. Syndromic X-linked intellectual disability segregating with a missense variant in RLIM.
Tønne E, Holdhus R, Stansberg C, Stray-Pedersen A, Petersen K, Brunner HG, Gilissen C, Hoischen A, Prescott T, Steen VM, Fiskerstrand T. Eur J Hum Genet. 2015 23(12):1652-6. 10.1038/ejhg.2015.30
41. BMET-34: drug repurposing discovers beta-sitosterol as an effective therapeutic agent against melanoma brain metastases in vivo.
Sundstrøm T, Varughese JK, Prestegarden L, Azuaje F, Røsland GV, Skaftnesmo KO, Ingham ES, Even L, Tam S, Tepper C, Petersen K, Ferrara KW, Tronstad KJ, Lund-Johansen M, Bjerkvig R, Thorsen FA. Neuro Oncol. 2015 17(Suppl 5):v52. 10.1093/neuonc/nov208.34
40. Distributed and interactive visual analysis of omics data.
Farag Y, Berven FS, Jonassen I, Petersen K, Barsnes H. J Proteomics. 2015 129:78-82. 10.1016/j.jprot.2015.05.029
2014
39. BM-34: new uses of old drugs for the clinical treatment of brain metastases.
Sundstrøm T, Varughese JK, Azuaje F, Prestegarden L, Petersen K, Tepper CG, Ingham E, Even L, Johnson S, Skaftnesmo KO, Lund-Johansen M, Bjerkvig R, Ferrara KW, Thorsen FA. Neuro Oncol. 2014 16(Suppl 5):v39. 10.1093/neuonc/nou240.33
37. Drug repurposing to treat melanoma brain metastases.
Sundstrøm T Varughese JK Azuaje F Petersen K Tepper CG Ingham E Even L Tam S Skaftnesmo KO Lund-Johansen M Bjerkvig R Ferrara KW Thorsen FA. Cancer Res. 2014; 74 (19_Supplement): 4036. 10.1158/1538-7445.AM2014-4036
36. Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.
Wik E, Trovik J, Kusonmano K, Birkeland E, Raeder MB, Pashtan I, Hoivik EA, Krakstad C, Werner HM, Holst F, Mjøs S, Halle MK, Mannelqvist M, Mauland KK, Oyan AM, Stefansson IM, Petersen K, Simon R, Cherniack AD, Meyerson M, Kalland KH, Akslen LA, Salvesen HB. Gynecol Oncol. 2014 134(3):599-606. 10.1016/j.ygyno.2014.06.026
35. Switch in FOXA1 status associates with endometrial cancer progression.
Tangen IL, Krakstad C, Halle MK, Werner HM, Oyan AM, Kusonmano K, Petersen K, Kalland KH, Akslen LA, Trovik J, Hurtado A, Salvesen HB. PLoS One. 2014 9(5):e98069. 10.1371/journal.pone.0098069
34. Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.
Hoivik EA, Kusonmano K, Halle MK, Berg A, Wik E, Werner HM, Petersen K, Oyan AM, Kalland KH, Krakstad C, Trovik J, Widschwendter M, Salvesen HB. Oncotarget. 2014 5(4):1052-61. 10.18632/oncotarget.1697
2013
33. Age-Dependent association between protein expression of the embryonic stem cell marker Cripto-1 and survival of glioblastoma patients.
Tysnes BB, Satran HA, Mork SJ, Margaryan NV, Eide GE, Petersen K, Strizzi L, Hendrix MJ. Transl Oncol. 2013 6(6):732-41. 10.1593/tlo.13427
32. Brain-specific gene signature of melanoma metastasis.
Sundstrøm T, Varughese JK, Harter P, Prestegarden L, Petersen K, Azuaje F, Tepper CG, Ingham E, Even L, Johnson S, Skaftnesmo KO, Lund-Johansen M, Bjerkvig R, Ferrara KW, Thorsen FA. Neuro-Oncology. 2013 27-27.
31. PIK3CA mutations but not PIK3CA amplifications are early events in the endometrial carcinogenesis.
Berg A, Mjos S, Kusonmano K, Hoivik E, Holst F, Halle M, Birkeland E, Werner H, Oyan A, Petersen K, Kalland K-H, Akslen L, Trovik J, Wik E, Kraksted C, Salvesen H. IJGC. 2013 23.
30. Pipelined data-flow delegated orchestration for data-intensive eScience workflows.
Subramanian S, Sztromwasser P, Puntervoll P, Petersen K. Int J Web Inf Syst. 2013 9. 10.1108/IJWIS-05-2013-0012
Seehuus SC, Taylor S, Petersen K, Aamodt RM. PLoS One. 2013 8(8):e69870. 10.1371/journal.pone.0069870
28. Gene set based integrated data analysis reveals phenotypic differences in a brain cancer model.
Petersen K, Rajcevic U, Abdul Rahim SA, Jonassen I, Kalland KH, Jimenez CR, Bjerkvig R, Niclou SP. PLoS One. 2013 8(7):e68288. 10.1371/journal.pone.0068288
27. High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition.
Wik E, Birkeland E, Trovik J, Werner HM, Hoivik EA, Mjos S, Krakstad C, Kusonmano K, Mauland K, Stefansson IM, Holst F, Petersen K, Oyan AM, Simon R, Kalland KH, Ricketts W, Akslen LA, Salvesen HB. Clin Cancer Res. 2013 19(9):2331-41. 10.1158/1078-0432.CCR-12-3413
26. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas.
Werner HM, Berg A, Wik E, Birkeland E, Krakstad C, Kusonmano K, Petersen K, Kalland KH, Oyan AM, Akslen LA, Trovik J, Salvesen HB. Mod Pathol. 2013 26(3):428-34. 10.1038/modpathol.2012.174
2012
Krakstad C, Birkeland E, Seidel D, Kusonmano K, Petersen K, Mjøs S, Hoivik EA, Wik E, Halle MK, Øyan AM, Kalland KH, Werner HM, Trovik J, Salvesen H. PLoS One. 2012 7(12):e52795. 10.1371/journal.pone.0052795
24. Direct data transfer between SOAP web services in orchestration.
Subramanian S, Sztromwasser P, Petersen K, Puntervoll P. iiWAS. 2012 91-100. 10.1145/2428736.2428753
23. KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer.
Birkeland E, Wik E, Mjøs S, Hoivik EA, Trovik J, Werner HM, Kusonmano K, Petersen K, Raeder MB, Holst F, Øyan AM, Kalland KH, Akslen LA, Simon R, Krakstad C, Salvesen HB. Br J Cancer. 2012 107(12):1997-2004. 10.1038/bjc.2012.477
22. Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status–consequences and potentials for pharmacological intervention.
Reikvam H, Hatfield KJ, Ersvaer E, Hovland R, Skavland J, Gjertsen BT, Petersen K, Bruserud O. Br J Haematol. 2012 156(4):468-80. 10.1111/j.1365-2141.2011.08960.x
2011
21. NGS research and service at the CBU.
Petersen K, Jonassen I. EMBnet.journal. 2011. 10.14806/ej.17.B.287
20. Hepatic in vitro toxicity assessment of PBDE congeners BDE47, BDE153 and BDE154 in Atlantic salmon (Salmo salar L.).
Søfteland L, Petersen K, Stavrum AK, Wu T, Olsvik PA. Aquat Toxicol. 2011 105(3-4):246-63. 10.1016/j.aquatox.2011.03.012
Sztromwasser P, Puntervoll P, Petersen K. J Integr Bioinform. 2011 8(2):163. 10.2390/biecoll-jib-2011-163
18. Are apparent negative effects of feeding GM MON810 maize to Atlantic salmon, Salmo salar, caused by confounding factors?
Sissener NH, Hemre GI, Lall SP, Sagstad A, Petersen K, Williams J, Rohloff J, Sanden M. Br J Nutr. 2011 106(1):42-56. 10.1017/S0007114510005726
17. A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia.
Apelseth TO, Hervig T, Wentzel-Larsen T, Petersen K, Reikvam H, Bruserud Ø. Eur Cytokine Netw. 2011 22(1):52-62. 10.1684/ecn.2011.0271
2009
16. iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype.
Rajcevic U, Petersen K, Knol JC, Loos M, Bougnaud S, Klychnikov O, Li KW, Pham TV, Wang J, Miletic H, Peng Z, Bjerkvig R, Jimenez CR, Niclou SP. Mol Cell Proteomics. 2009 8(11):2595-612. 10.1074/mcp.M900124-MCP200
15. Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype.
Johannessen TC, Wang J, Skaftnesmo KO, Sakariassen PØ, Enger PØ, Petersen K, Øyan AM, Kalland KH, Bjerkvig R, Tysnes BB. Neuropathol Appl Neurobiol. 2009 35(4):380-93. 10.1111/j.1365-2990.2008.01008.x
14. Genome-wide transcription analysis of histidine-related cataract in Atlantic salmon (Salmo salar L). Mol Vis. 2009 15:1332-50. Abstract
13. Tumor endothelium is characterized by a matrix remodeling signature.
van Beijnum JR, Petersen K, Griffioen AW. Front Biosci (Schol Ed). 2009 1(1):216-25. 10.2741/S21
Ke XS, Qu Y, Rostad K, Li WC, Lin B, Halvorsen OJ, Haukaas SA, Jonassen I, Petersen K, Goldfinger N, Rotter V, Akslen LA, Oyan AM, Kalland KH. PLoS One. 2009 4(3):e4687. 10.1371/journal.pone.0004687
2008
11. Pharmacokinetics and transcriptional effects of the anti-salmon lice drug emamectin benzoate in Atlantic salmon (Salmo salar L.).
Olsvik PA, Lie KK, Mykkeltvedt E, Samuelsen OB, Petersen K, Stavrum AK, Lunestad BT. BMC Pharmacol. 2008 8:16. 10.1186/1471-2210-8-16
10. Analysis of gene-expression data using J-Express.
Stavrum AK, Petersen K, Jonassen I, Dysvik B. Curr Protoc Bioinformatics. 2008 Chapter 7:Unit 7.3. 10.1002/0471250953.bi0703s21
2007
9. Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats.
Stuhr LE, Raa A, Oyan AM, Kalland KH, Sakariassen PO, Petersen K, Bjerkvig R, Reed RK. J Neurooncol. 2007 85(2):191-202. 10.1007/s11060-007-9407-2
8. The influence of the NOD Nss1/Idd5 loci on sialadenitis and gene expression in salivary glands of congenic mice.
Hjelmervik TO, Lindqvist AK, Petersen K, Johannesson M, Stavrum AK, Johansson A, Jonsson R, Holmdahl R, Bolstad AI. Arthritis Res Ther. 2007 9(5):R99. 10.1186/ar2300
7. Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization.
Petersen K, Oyan AM, Rostad K, Olsen S, Bø TH, Salvesen HB, Gjertsen BT, Bruserud O, Halvorsen OJ, Akslen LA, Steen VM, Jonassen I, Kalland KH. Anal Biochem. 2007 366(1):46-58. 10.1016/j.ab.2007.03.013
6. Gene expression profiles in rat brain disclose CNS signature genes and regional patterns of functional specialisation.
Stansberg C, Vik-Mo AO, Holdhus R, Breilid H, Srebro B, Petersen K, Jørgensen HA, Jonassen I, Steen VM. BMC Genomics. 2007 Apr 4;8:94. 10.1186/1471-2164-8-94
2006
Rayner TF, Rocca-Serra P, Spellman PT, Causton HC, Farne A, Holloway E, Irizarry RA, Liu J, Maier DS, Miller M, Petersen K, Quackenbush J, Sherlock G, Stoeckert CJ Jr, White J, Whetzel PL, Wymore F, Parkinson H, Sarkans U, Ball CA, Brazma A. BMC Bioinformatics. 2006 7:489. 10.1186/1471-2105-7-489
4. Angiogenesis-independent tumor growth mediated by stem-like cancer cells.
Sakariassen PØ, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, Chekenya M, Peters H, Lende G, Kalland KH, Øyan AM, Petersen K, Jonassen I, van der Kogel A, Feuerstein BG, Terzis AJ, Bjerkvig R, Enger PØ. Proc Natl Acad Sci USA. 2006 103(44):16466-71. 10.1073/pnas.0607668103
2005
Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Arthritis Rheum. 2005 52(5):1534-44. 10.1002/art.21006
2003
2. Ab initio modelling of the N-terminal domain of the secretin receptors.
Taylor WR, Munro RE, Petersen K, Bywater RP. Comput Biol Chem. 2003 27(2):103-14. 10.1016/s1476-9271(03)00020-3
1. Modelling zinc-binding proteins with GADGET: genetic algorithm and distance geometry for exploring topology.
Petersen K, Taylor WR. J Mol Biol. 2003 325(5):1039-59. 10.1016/s0022-2836(02)01220-2